BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a significant decline in short interest in November. As of November 15th, there was short interest totalling 7,300 shares, a decline of 67.1% from the October 31st total of 22,200 shares. Based on an average daily volume of 23,900 shares, the days-to-cover ratio is currently 0.3 days.

BetterLife Pharma Stock Up 10.1 %

BETRF traded up $0.01 during trading on Wednesday, hitting $0.09. The company’s stock had a trading volume of 25,900 shares, compared to its average volume of 28,930. The firm has a market capitalization of $11.75 million, a P/E ratio of -2.75 and a beta of 1.27. BetterLife Pharma has a twelve month low of $0.03 and a twelve month high of $0.15. The stock’s fifty day moving average price is $0.09 and its 200-day moving average price is $0.09.

BetterLife Pharma (OTCMKTS:BETRF) last released its earnings results on Wednesday, September 25th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.